110 results
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
Initiation of ART in HIV ... patients with Opportunistic ... of starting OI treatment ... Therapy #HAART #HIV ... #Opportunistic
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Women with in HIV-AIDS ... known to have HIV ... diagnosed with HIV ... IDSA #Prevention #Treatment ... #management #opportunistic
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
CNS Infection in HIV ... CNS Opportunistic ... present in 15% of cases ... Antimicrobial treatment ... Demyelinating disease caused
Acute Retroviral Syndrome
Acute Retroviral Syndrome is the symptomatic presentation of acute human immunodeficiency virus infection

 •
elevation • Nausea ... Presentations: • Opportunistic ... 14%), in which case ... opportunistic infections ... antibody test) Treatment
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Infections in HIV-AIDS ... • In rare cases ... PO (or 400 mg IV ... IDSA #Prevention #Treatment ... #management #opportunistic
Pneumocystis jirovecii Pneumonia 
Clinical 
 • Caused by Pneumocystis jirovecii (formerly carinil) 
 • Immunocompromised host
Clinical • Caused ... Immunocompromised host (HIV ... ) • Seen in HIV ... often elevated Treatment
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
of HIV/AIDS patients ... previously diagnosed opportunistic ... of preexisting opportunistic ... unintentional weight loss, nausea ... • Treat for opportunistic
Drug Induced Liver Injury (DILI) - Stepwise Diagnosis Algorithm
DILI suspicion
Features toxic aetiology: Skin involvement, Kidney injury,
non-essential drug/HDS treatments ... for alternative causes ... Viral infections (HAV ... , HBV, HCV, HEV,
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis in HIV-AIDS ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Infections in HIV-AIDS ... to 5 mg/kg/day IV ... IDSA #Prevention #Treatment ... #management #opportunistic